Late onset neutropenia associated with clozapine

Journal of Clinical Psychopharmacology

Volumn 31, Issue 6, 2011, Pages 780-781

  Raja, Michele ^a   Azzoni, Antonella ^b   Maisto, Giovanni ^c  

^a Private Practice   (Italy)

^b SPIRITO SANTO HOSPITAL   (Italy)

^c ASL RM/E   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; METFORMIN; OLANZAPINE; QUETIAPINE; RISPERIDONE; SCOPOLAMINE;

ABDOMINAL PAIN; ADULT; AKATHISIA; BEDTIME DOSAGE; BIPOLAR DISORDER; CASE REPORT; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOSPITAL ADMISSION; HUMAN; LETTER; MALE; NEUTROPENIA; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIORITY JOURNAL; REMISSION; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PSYCHOTIC DISORDERS; TIME FACTORS;

EID: 80755168983     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318234eec2     Document Type: Letter

References (14)

1. Munro J, O'Sullivan D, Andrews C, et al. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry. 1999;175:576-580.
2. Pascoe SJ. The adjunctive use of a centralized database in the monitoring of clozapine-related neutropenia. Pharmacoepidemiol Drug Saf. 2003;12(5):395-398. (Pubitemid 36903375)
3. Atkin K, Kendall F, Gould D, et al. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry. 1996;169:483-488.
4. Alvir J, Ma J, Lieberman JA, et al. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med. 1993;329:162-167. (Pubitemid 23195736)
5. Senechal A, Landry P, Deschamps R, et al. Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs. Encephale. 2002;28(6 Pt 1):567-569. (Pubitemid 36132926)
6. Patel NC, Dorson PG, Bettinger TL. Sudden late onset of clozapine-induced agranulocytosis. Ann Pharmacother. 2002;36:1012-1015. (Pubitemid 34564387)
7. Small JG, Weber MC, Klapper MH, et al. Rechallenge of late-onset neutropenia with clozapine. J Clin Psychopharmacol. 2005;25:185-186.
8. Kutscher EC, Robbins GP, Kennedy WK, et al. Clozapine-induced leukopenia successfully treated with lithium. Am J Health Sys Pharm. 2007;64:2027-2031. (Pubitemid 47530408)
9. Nongpiur A, Praharaj SK, Sarkar S, et al. Delayed onset of clozapine-induced leucopenia. Am J Ther. 2010. [Epub ahead of print]
10. Oyesanmi O, Kunkel EJ, Monti DA, et al. Hematologic side effects of psychotropics. Psychosomatics. 1999;40:414-421. (Pubitemid 29407217)
11. Stubner S, Grohmann R, Engel R, et al. Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry. 2004; 37(suppl 1):S70YS78. (Pubitemid 38658333)
12. Gerson SL. ClozapineVdeciphering the risks. N Engl J Med. 1993;329:204-205.
13. Gerson SL. G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry. 1994;55:139-142. (Pubitemid 24353039)
14. Tamam L, Kulan E, Ozpoyraz N. Late onset neutropenia during clozapine treatment. Psychiatr Clin Neurosci. 2001;55(5): 547-548. (Pubitemid 32938812)